Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction
The own observation of treatment of patients with advanced kidney cancer by sunitinib — the angiogenesis blocker and tyrosine kinases inhibitor medication — is presented. 44 patients having distant metastases of renal cancer underwent therapy. In the course of treatment in the group of favorable and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peoples’ Friendship University of Russia (RUDN University)
2013-12-01
|
| Series: | RUDN Journal of Medicine |
| Subjects: | |
| Online Access: | http://journals.rudn.ru/medicine/article/view/2703 |
| id |
doaj-9132775cc586495789864560ae136a27 |
|---|---|
| record_format |
Article |
| spelling |
doaj-9132775cc586495789864560ae136a272020-11-24T20:58:32ZengPeoples’ Friendship University of Russia (RUDN University)RUDN Journal of Medicine2313-02452313-02612013-12-010342482703Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correctionA A Klimenko0S A Ivanov1Российский научный центр рентгенорадиологии Минздрава РоссииРоссийский научный центр рентгенорадиологии Минздрава РоссииThe own observation of treatment of patients with advanced kidney cancer by sunitinib — the angiogenesis blocker and tyrosine kinases inhibitor medication — is presented. 44 patients having distant metastases of renal cancer underwent therapy. In the course of treatment in the group of favorable and intermediate prognosis ( n = 44), disease-free survival was 13 months, the overall survival rate — 22 months. Analyzed all complications associated with the use of sunitinib. Data obtained allow to recommend sunitinib for the treatment of patients with metastatic renal cell carcinoma with the timely prevention of complications of this treatment.http://journals.rudn.ru/medicine/article/view/2703почечно-клеточный ракангиогенезтаргетная терапиянежелательные явления |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
A A Klimenko S A Ivanov |
| spellingShingle |
A A Klimenko S A Ivanov Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction RUDN Journal of Medicine почечно-клеточный рак ангиогенез таргетная терапия нежелательные явления |
| author_facet |
A A Klimenko S A Ivanov |
| author_sort |
A A Klimenko |
| title |
Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| title_short |
Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| title_full |
Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| title_fullStr |
Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| title_full_unstemmed |
Analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| title_sort |
analysis of complications arising from treatment of advanced kidney cancer by sunitinib and their correction |
| publisher |
Peoples’ Friendship University of Russia (RUDN University) |
| series |
RUDN Journal of Medicine |
| issn |
2313-0245 2313-0261 |
| publishDate |
2013-12-01 |
| description |
The own observation of treatment of patients with advanced kidney cancer by sunitinib — the angiogenesis blocker and tyrosine kinases inhibitor medication — is presented. 44 patients having distant metastases of renal cancer underwent therapy. In the course of treatment in the group of favorable and intermediate prognosis ( n = 44), disease-free survival was 13 months, the overall survival rate — 22 months. Analyzed all complications associated with the use of sunitinib. Data obtained allow to recommend sunitinib for the treatment of patients with metastatic renal cell carcinoma with the timely prevention of complications of this treatment. |
| topic |
почечно-клеточный рак ангиогенез таргетная терапия нежелательные явления |
| url |
http://journals.rudn.ru/medicine/article/view/2703 |
| work_keys_str_mv |
AT aaklimenko analysisofcomplicationsarisingfromtreatmentofadvancedkidneycancerbysunitinibandtheircorrection AT saivanov analysisofcomplicationsarisingfromtreatmentofadvancedkidneycancerbysunitinibandtheircorrection |
| _version_ |
1716785669082185728 |